Canada’s Jamp Creates Dedicated Biosimilars Division

As It Prepares To Launch Alvotech’s Higher-Strength Adalimumab Humira Rival

 
• By David Wallace
  
Montreal skyline sunrise photo dawn
Montreal-based Jamp welcomes a new dawn for its biosimilars business • Source: James Byrne / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business